Perrigo (PRGO) Total Debt (2013 - 2026)
Perrigo's (PRGO) quarterly Total Debt came in at $3.6 billion in Q1 2026, little changed year-on-year from $3.6 billion in Q1 2025, and little changed on a QoQ basis from $3.6 billion in Q4 2025.
Perrigo (PRGO) Total Debt (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Total Debt data on file, last reported at $3.6 billion in Q1 2026.
- On a quarterly basis, Total Debt changed 0.14% year-over-year to $3.6 billion in Q1 2026; TTM through Mar 2026 was $3.6 billion, a 0.14% change from a year earlier, with the FY2025 full-year figure at $3.6 billion, up 0.61% from the prior year.
- Total Debt for Q1 2026 stood at $3.6 billion, roughly flat from $3.6 billion in the prior quarter.
- Over the last five years, Total Debt for PRGO reached as high as $4.8 billion in Q3 2024 and fell as low as $3.5 billion in Q2 2022.
- Historically, Total Debt has averaged $3.9 billion across 5 years, with a median of $4.1 billion in 2024.
- Across the five-year window, Total Debt grew 16.68% in 2023 and dropped 23.32% in 2025, its largest moves.
- Year by year, Total Debt stood at $4.1 billion in 2022, then declined by 0.81% to $4.1 billion in 2023, then fell by 11.18% to $3.6 billion in 2024, then rose by 0.61% to $3.6 billion in 2025, then dropped by 0.21% to $3.6 billion in 2026.
- Per Business Quant data, the three most recent Total Debt figures were $3.6 billion in Q1 2026, $3.6 billion in Q4 2025, and $3.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | 3.63 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 3.63 Bn |
| Dec 31, 2025 | 3.64 Bn |
| Sep 27, 2025 | 3.64 Bn |
| Jun 28, 2025 | 3.65 Bn |
| Mar 29, 2025 | 3.63 Bn |
| Dec 31, 2024 | 3.62 Bn |
| Sep 28, 2024 | 4.75 Bn |
| Jun 29, 2024 | 4.06 Bn |
| Mar 30, 2024 | 4.07 Bn |
| Dec 31, 2023 | 4.07 Bn |
| Sep 30, 2023 | 4.09 Bn |
| Jul 1, 2023 | 4.09 Bn |
| Apr 1, 2023 | 4.10 Bn |
| Dec 31, 2022 | 4.11 Bn |
| Oct 1, 2022 | 4.11 Bn |
| Jul 2, 2022 | 4.12 Bn |
| Apr 2, 2022 | 3.52 Bn |
| Dec 31, 2021 | 3.52 Bn |
| Oct 2, 2021 | 3.55 Bn |
| Jul 3, 2021 | 3.56 Bn |